Chemomab Therapeutics Ltd (NAS:CMMB)
$ 2 -0.03 (-1.48%) Market Cap: 28.72 Mil Enterprise Value: 16.78 Mil PE Ratio: 0 PB Ratio: 2.92 GF Score: 39/100

Q4 2021 Chemomab Therapeutics Ltd Earnings Call Transcript

Mar 09, 2022 / 01:00PM GMT
Release Date Price: $3.79 (+4.41%)
Operator

Greetings. Welcome to Chemomab's fourth-quarter and full-year 2021 earnings call. (Operator Instructions) Please note this conference is being recorded.

I will now turn the conference over to Barbara Lindheim, Vice President of Investor Relations. Thank you. You may begin.

Barbara Lindheim
Chemomab Therapeutics Ltd. - Consulting Vice President, Investor & Public Relations

Welcome to the Chemomab Therapeutics 2021 fourth-quarter and full-year results conference call. Thank you for attending.

I am Barbara Lindheim, Consulting Vice President of Communications at Chemomab. With me today are Dale Pfost, our Chairman and CEO; Don Marvin, CFO, Chief Operating Officer and the Executive Vice President; Dr. David Wiener, Chemomab Interim Chief Medical Officer; and Dr. Adi Mor, our Co-Founder and Chief Scientific Officer.

Before I turn the call over to Dale, please take note of our forward-looking statements. Today's call may contain forward-looking statements, which may be identified by words such as may, could, will, expect, intend,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot